4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide

C147H146F6N38O19S2 — CID 172984612

IUPAC4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide
SMILESCCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(n2nc[nH]c2=O)C1.CCc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2ncc(-c3ccccc3)[nH]2)cc1-n1nn[nH]c1=O.CO/N=C(\C(=O)C[C@@H]1C(=O)N2C(n3nnnc3[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1cnc(N)s1.Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(N2NCNC2=O)c1.Cc1nc(C(=O)NCN2N=NCC2=O)c(O)c2ccc(Oc3ccccc3)cc12.O=C1NCNN1c1cccc(-c2noc(-c3ccccc3F)n2)c1
InChIInChI=1S/C33H37N9O3.C30H36F3N5O2.C25H21F2N5O4.C23H23N9O4S2.C20H17N5O4.C16H12FN5O2/c1-5-23-12-11-22(15-29(23)42-33(45)38-39-40-42)18-41(21(4)31-36-17-28(37-31)24-9-7-6-8-10-24)32(44)27(34)16-26-19(2)13-25(30(35)43)14-20(26)3;1-3-22-14-24(10-11-25(22)15-37-16-26(17-37)38-29(39)34-19-35-38)20(2)36-40-18-21-9-12-27(23-7-5-4-6-8-23)28(13-21)30(31,32)33;1-14-5-8-20(30-21(14)15-3-2-4-17(11-15)32-23(34)28-13-29-32)31-22(33)24(9-10-24)16-6-7-18-19(12-16)36-25(26,27)35-18;1-36-27-18(17-9-25-22(24)38-17)16(33)8-14-20(34)31-19(32-23(35)26-28-29-32)13(11-37-21(14)31)10-30-7-3-5-12-4-2-6-15(12)30;1-12-16-9-14(29-13-5-3-2-4-6-13)7-8-15(16)19(27)18(23-12)20(28)21-11-25-17(26)10-22-24-25;17-13-7-2-1-6-12(13)15-20-14(21-24-15)10-4-3-5-11(8-10)22-16(23)18-9-19-22/h6-15,17,21,27H,5,16,18,34H2,1-4H3,(H2,35,43)(H,36,37)(H,38,40,45);9-14,19,23,26H,3-8,15-18H2,1-2H3,(H,34,35,39);2-8,11-12,29H,9-10,13H2,1H3,(H,28,34)(H,30,31,33);3,5,7,9,14,21H,2,4,6,8,10-11H2,1H3,(H2-,24,25,26,27,29,35);2-9,27H,10-11H2,1H3,(H,21,28);1-8,19H,9H2,(H,18,23)/b;36-20+;;;;/t21-,27-;;;14-,21-;;/m0..1../s1
InChIKeyKRXSFQXSABIJLR-MZXAOBEFSA-N
MW2927.15 g/mol
LogP18.97
Rot. Bonds41

About 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide

4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide (PubChem CID 172984612) has the molecular formula C147H146F6N38O19S2 and a molecular weight of 2927.15 g/mol. Its IUPAC name is 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide.

Molecular Properties

Compound Name4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide
PubChem CID172984612
Molecular FormulaC147H146F6N38O19S2
Molecular Weight2927.15 g/mol
Exact Mass2925.10
IUPAC Name4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide
SMILESCCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(n2nc[nH]c2=O)C1.CCc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2ncc(-c3ccccc3)[nH]2)cc1-n1nn[nH]c1=O.CO/N=C(\C(=O)C[C@@H]1C(=O)N2C(n3nnnc3[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1cnc(N)s1.Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(N2NCNC2=O)c1.Cc1nc(C(=O)NCN2N=NCC2=O)c(O)c2ccc(Oc3ccccc3)cc12.O=C1NCNN1c1cccc(-c2noc(-c3ccccc3F)n2)c1
InChIInChI=1S/C33H37N9O3.C30H36F3N5O2.C25H21F2N5O4.C23H23N9O4S2.C20H17N5O4.C16H12FN5O2/c1-5-23-12-11-22(15-29(23)42-33(45)38-39-40-42)18-41(21(4)31-36-17-28(37-31)24-9-7-6-8-10-24)32(44)27(34)16-26-19(2)13-25(30(35)43)14-20(26)3;1-3-22-14-24(10-11-25(22)15-37-16-26(17-37)38-29(39)34-19-35-38)20(2)36-40-18-21-9-12-27(23-7-5-4-6-8-23)28(13-21)30(31,32)33;1-14-5-8-20(30-21(14)15-3-2-4-17(11-15)32-23(34)28-13-29-32)31-22(33)24(9-10-24)16-6-7-18-19(12-16)36-25(26,27)35-18;1-36-27-18(17-9-25-22(24)38-17)16(33)8-14-20(34)31-19(32-23(35)26-28-29-32)13(11-37-21(14)31)10-30-7-3-5-12-4-2-6-15(12)30;1-12-16-9-14(29-13-5-3-2-4-6-13)7-8-15(16)19(27)18(23-12)20(28)21-11-25-17(26)10-22-24-25;17-13-7-2-1-6-12(13)15-20-14(21-24-15)10-4-3-5-11(8-10)22-16(23)18-9-19-22/h6-15,17,21,27H,5,16,18,34H2,1-4H3,(H2,35,43)(H,36,37)(H,38,40,45);9-14,19,23,26H,3-8,15-18H2,1-2H3,(H,34,35,39);2-8,11-12,29H,9-10,13H2,1H3,(H,28,34)(H,30,31,33);3,5,7,9,14,21H,2,4,6,8,10-11H2,1H3,(H2-,24,25,26,27,29,35);2-9,27H,10-11H2,1H3,(H,21,28);1-8,19H,9H2,(H,18,23)/b;36-20+;;;;/t21-,27-;;;14-,21-;;/m0..1../s1
InChIKeyKRXSFQXSABIJLR-MZXAOBEFSA-N
XLogP18.97
TPSA730.19 Ų
H-Bond Donors13
H-Bond Acceptors45
Rotatable Bonds41
Heavy Atoms212
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002927.15
LogP ≤ 518.97
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1045

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide?
The IUPAC name of 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide (CID 172984612) is 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide.
What is the SMILES notation for 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide?
The canonical SMILES for 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide is CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(n2nc[nH]c2=O)C1.CCc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2ncc(-c3ccccc3)[nH]2)cc1-n1nn[nH]c1=O.CO/N=C(\C(=O)C[C@@H]1C(=O)N2C(n3nnnc3[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1cnc(N)s1.Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(N2NCNC2=O)c1.Cc1nc(C(=O)NCN2N=NCC2=O)c(O)c2ccc(Oc3ccccc3)cc12.O=C1NCNN1c1cccc(-c2noc(-c3ccccc3F)n2)c1.
What is the InChIKey of 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide?
The InChIKey is KRXSFQXSABIJLR-MZXAOBEFSA-N. The full InChI is InChI=1S/C33H37N9O3.C30H36F3N5O2.C25H21F2N5O4.C23H23N9O4S2.C20H17N5O4.C16H12FN5O2/c1-5-23-12-11-22(15-29(23)42-33(45)38-39-40-42)18-41(21(4)31-36-17-28(37-31)24-9-7-6-8-10-24)32(44)27(34)16-26-19(2)13-25(30(35)43)14-20(26)3;1-3-22-14-24(10-11-25(22)15-37-16-26(17-37)38-29(39)34-19-35-38)20(2)36-40-18-21-9-12-27(23-7-5-4-6-8-23)28(13-21)30(31,32)33;1-14-5-8-20(30-21(14)15-3-2-4-17(11-15)32-23(34)28-13-29-32)31-22(33)24(9-10-24)16-6-7-18-19(12-16)36-25(26,27)35-18;1-36-27-18(17-9-25-22(24)38-17)16(33)8-14-20(34)31-19(32-23(35)26-28-29-32)13(11-37-21(14)31)10-30-7-3-5-12-4-2-6-15(12)30;1-12-16-9-14(29-13-5-3-2-4-6-13)7-8-15(16)19(27)18(23-12)20(28)21-11-25-17(26)10-22-24-25;17-13-7-2-1-6-12(13)15-20-14(21-24-15)10-4-3-5-11(8-10)22-16(23)18-9-19-22/h6-15,17,21,27H,5,16,18,34H2,1-4H3,(H2,35,43)(H,36,37)(H,38,40,45);9-14,19,23,26H,3-8,15-18H2,1-2H3,(H,34,35,39);2-8,11-12,29H,9-10,13H2,1H3,(H,28,34)(H,30,31,33);3,5,7,9,14,21H,2,4,6,8,10-11H2,1H3,(H2-,24,25,26,27,29,35);2-9,27H,10-11H2,1H3,(H,21,28);1-8,19H,9H2,(H,18,23)/b;36-20+;;;;/t21-,27-;;;14-,21-;;/m0..1../s1.
What are the key properties of 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide?
4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide has a molecular weight of 2927.15 g/mol, XLogP of 18.97, 41 rotatable bonds, 13 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(2S)-2-amino-3-[[4-ethyl-3-(5-oxo-1H-tetrazol-4-yl)phenyl]methyl-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]-3-oxopropyl]-3,5-dimethylbenzamide;1-[(6R,7R)-7-[(3E)-3-(2-amino-1,3-thiazol-5-yl)-3-methoxyimino-2-oxopropyl]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]tetrazol-5-olate;2-[1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidin-3-yl]-4H-1,2,4-triazol-3-one;1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[5-methyl-6-[3-(5-oxo-1,2,4-triazolidin-1-yl)phenyl]-2-pyridinyl]cyclopropane-1-carboxamide;2-[3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-1,2,4-triazolidin-3-one;4-hydroxy-1-methyl-N-[(5-oxo-4H-triazol-1-yl)methyl]-7-phenoxyisoquinoline-3-carboxamide is sourced from PubChem (CID 172984612), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).